GelteqGELS -3.57%10 PS Ratio is 60.00 as of Jul. 02, 2026, which is 48% below its 10-year median of 114.59. GuruFocus rates GELS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 949 Drug Manufacturers companies, Gelteq ranks worse than 96.84% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Gelteq's share price is $0.66.
Gelteq's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01. Hence, Gelteq's PS Ratio for today is 60.00.
The historical rank and industry rank for Gelteq's PS Ratio or its related term are showing as below:
GELS'
s PS Ratio Range Over the Past 10 Years
Min: 35.17 Med: 114.59 Max: 470
Current: 59.99
During the past 6 years, Gelteq's highest PS Ratio was 470.00. The lowest was 35.17. And the median was 114.59.
GELS's PS Ratio is ranked worse than 96.84% of 949
companies
in the Drug Manufacturers industry
Industry Median: 2.27
vs GELS: 59.99
Gelteq's Revenue per Sharefor the
six
months ended in Dec. 2025 was $0.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
During the past 3 years, the average Revenue per Share Growth Rate was 2.90% per year.
During the past 6 years, Gelteq's highest 3-Year average Revenue per Share Growth Rate was 2.90% per year. The lowest was 2.90% per year. And the median was 2.90% per year.
Back to Basics: PS Ratio
Gelteq (NAS:GELS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Gelteq PS Ratio Related Terms
Gelteq PS Ratio Historical Data
* Premium members only.
The historical data trend for Gelteq's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Gelteq's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gelteq PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gelteq's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gelteq's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Gelteq's Share Price of today is $0.66.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gelteq's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Gelteq (GELS) has a PS Ratio of 60.00 as of Jul. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gelteq and its competitors. This is 48% below median its historical median of 114.59. Over the past decade, Gelteq's PS Ratio has ranged from 35.17 to 470.00. According to the industry distribution chart, Gelteq ranks #919 out of 949 companies in the Drug Manufacturers industry, placing it in the top 96.8%.
Is Gelteq's PS Ratio too high?
Gelteq's current PS Ratio of 60.00 is 48% below median its 10-year median of 114.59. Over the past 10 years, this metric has ranged from a low of 35.17 to a high of 470.00. The Drug Manufacturers industry median PS Ratio is 2.27. Gelteq's value of 60.00 is 2543.2% above this industry median. Based on the distribution chart, Gelteq ranks #919 out of 949 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Gelteq has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's PS Ratio compare to YCBD and AKAN?
According to the Drug Manufacturers industry distribution chart, Gelteq ranks #919 out of 949 companies for PS Ratio. This places Gelteq in the lower half of its industry. The industry median PS Ratio is 2.27. Gelteq's value of 60.00 is 2543.2% above this benchmark. Historically, Gelteq's own PS Ratio has ranged from 35.17 to 470.00 over the past decade. While the company's 10-year median is 114.59 vs. the industry median of 2.27, Gelteq has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.27, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gelteq's current PS Ratio of 60.00 is 2543.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gelteq and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gelteq's current PS Ratio is 60.00, which is 48% below median its own 10-year median of 114.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current PS Ratio of 60.00. The current PS Ratio is 60.00, which is 48% below median its 10-year median of 114.59 and 2543.2% above the Drug Manufacturers industry median of 2.27. Gelteq's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Gelteq (GELS), the current PS Ratio is 60.00 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
10GF Score
Get the complete analysis for GELS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GELS has been successfully added to your 
